BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16146782)

  • 1. Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2.
    Thornton AM
    Front Biosci; 2006 Jan; 11():921-7. PubMed ID: 16146782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
    Antov A; Yang L; Vig M; Baltimore D; Van Parijs L
    J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of T-cell activation by CD4+ CD25+ suppressor T cells.
    Shevach EM; McHugh RS; Piccirillo CA; Thornton AM
    Immunol Rev; 2001 Aug; 182():58-67. PubMed ID: 11722623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
    Bayer AL; Yu A; Malek TR
    J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.
    Antony PA; Restifo NP
    J Immunother; 2005; 28(2):120-8. PubMed ID: 15725955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta and CD4+CD25+ regulatory T cells.
    Huber S; Schramm C
    Front Biosci; 2006 Jan; 11():1014-23. PubMed ID: 16146793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7.
    Peffault de Latour R; Dujardin HC; Mishellany F; Burlen-Defranoux O; Zuber J; Marques R; Di Santo J; Cumano A; Vieira P; Bandeira A
    Blood; 2006 Oct; 108(7):2300-6. PubMed ID: 16763207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.
    Curotto de Lafaille MA; Lino AC; Kutchukhidze N; Lafaille JJ
    J Immunol; 2004 Dec; 173(12):7259-68. PubMed ID: 15585848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance.
    Chen W
    Front Biosci; 2006 May; 11():1360-70. PubMed ID: 16368522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.
    Yu A; Malek TR
    J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.
    Malek TR; Yu A; Vincek V; Scibelli P; Kong L
    Immunity; 2002 Aug; 17(2):167-78. PubMed ID: 12196288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.
    Bensinger SJ; Walsh PT; Zhang J; Carroll M; Parsons R; Rathmell JC; Thompson CB; Burchill MA; Farrar MA; Turka LA
    J Immunol; 2004 May; 172(9):5287-96. PubMed ID: 15100267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.
    Turka LA; Walsh PT
    Front Biosci; 2008 Jan; 13():1440-6. PubMed ID: 17981641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
    Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
    J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes.
    Inaba H; Geiger TL
    Int Immunol; 2006 Jul; 18(7):1043-54. PubMed ID: 16702166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4
    Hernandez R; LaPorte KM; Hsiung S; Santos Savio A; Malek TR
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34475132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.
    Moseman EA; Liang X; Dawson AJ; Panoskaltsis-Mortari A; Krieg AM; Liu YJ; Blazar BR; Chen W
    J Immunol; 2004 Oct; 173(7):4433-42. PubMed ID: 15383574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.